Home LiteratureArticle Details
PMID: 12119342 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Identification of the lateral interaction surfaces of human histocompatibility leukocyte antigen (HLA)-DM with HLA-DR1 by formation of tethered complexes that present enhanced HLA-DM catalysis.

The Journal of experimental medicine ·Vol. 196 ·No. 2 ·2002-07-15 ·Pages 173-83

Stratikos E, Mosyak L, Zaller DM, Wiley DC

Abstract

Human histocompatibility leukocyte antigen (HLA)-DM is a major histocompatibility complex (MHC)-like protein that catalyzes exchange of antigenic peptides from MHC class II molecules. To investigate the molecular details of this catalysis we created four covalent complexes between HLA-DM and the MHC class II allele DR1. We introduced a disulfide bond between the naturally occurring cysteine beta46 on HLA-DM and an engineered cysteine on the end of a linker attached to either the NH(2)- or the COOH terminus of an antigenic peptide that is tightly bound on DR1. We find that when DM is attached to the NH(2) terminus of the peptide, it can, for all linker lengths tested, catalyze exchange of the peptide with a half-life a few minutes (compared with uncatalyzed t(1/2) > 100 h). This rate, which is several orders of magnitude greater than the one we obtain in solution assays using micromolar concentrations of HLA-DM, is dominated by a concentration independent factor, indicating an intramolecular catalytic interaction within the complex. A similar complex formed at the COOH terminus of the peptide shows no sign of DM-specific intramolecular catalysis. Restrictions on the possible interaction sites imposed by the length of the linkers indicate that the face of DR1 that accommodates the NH(2) terminus of the antigenic peptide interacts with the lateral face of HLA-DM that contains cysteine beta46.

MeSH Terms
Amino Acid Sequence Animals Binding Sites Catalysis Cell Line Cysteine/chemistry HLA-D Antigens/chemistry,genetics,metabolism HLA-DR1 Antigen/chemistry,genetics,metabolism Humans In Vitro Techniques Kinetics Macromolecular Substances Models, Molecular Molecular Sequence Data Oligopeptides/chemistry,genetics,metabolism Protein Conformation Recombinant Proteins/chemistry,genetics,metabolism
Chemicals
HLA-D Antigens HLA-DM antigens HLA-DR1 Antigen Macromolecular Substances Oligopeptides Recombinant Proteins Cysteine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Stratikos Efstratios
Department of Cellular and Molecular Biology, Howard Hughes Medical Institute, Harvard University, Cambridge, MA 02138, USA. [email protected]
Mosyak Lidia
Zaller Dennis M
Wiley Don C
References (27)
27 references, click to expand
  1. Deviant trafficking of I-Ad mutant molecules is reflected in their peptide binding properties.
    Eur J Immunol. 1999 Sep;29(9):2729-39 PMID: 10508247
  2. Cutting edge: a single, essential hydrogen bond controls the stability of peptide-MHC class II complexes.
    J Immunol. 1999 Oct 1;163(7):3567-71 PMID: 10490947
  3. Determinants of the peptide-induced conformational change in the human class II major histocompatibility complex protein HLA-DR1.
    J Biol Chem. 2000 Jan 21;275(3):2165-73 PMID: 10636922
  4. HLA-DM recognizes the flexible conformation of major histocompatibility complex class II.
    J Exp Med. 2000 Dec 18;192(12):1697-706 PMID: 11120767
  5. Determination of the HLA-DM interaction site on HLA-DR molecules.
    Immunity. 2000 Oct;13(4):517-27 PMID: 11070170
  6. Energetic asymmetry among hydrogen bonds in MHC class II*peptide complexes.
    Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9231-6 PMID: 11470892
  7. Transmembrane domain-mediated colocalization of HLA-DM and HLA-DR is required for optimal HLA-DM catalytic activity.
    J Immunol. 2001 Nov 1;167(9):5167-74 PMID: 11673529
  8. The kinetic basis of peptide exchange catalysis by HLA-DM.
    Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12450-5 PMID: 11606721
  9. A precise method for the determination of whole blood and plasma sulfhydryl groups.
    Anal Biochem. 1979 Feb;93(1):98-102 PMID: 434474
  10. Interaction between proteins localized in membranes.
    Proc Natl Acad Sci U S A. 1986 Sep;83(17):6258-62 PMID: 3018721
  11. A kinetic intermediate in the reaction of an antigenic peptide and I-Ek.
    Nature. 1989 Jan 19;337(6204):274-6 PMID: 2536141
  12. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding.
    Nature. 1990 Jun 14;345(6276):615-8 PMID: 2190094
  13. Structural and functional aspects of HLA class II glycoproteins and the associated invariant chain.
    Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:309-18 PMID: 2639757
  14. Structural intermediates in the reactions of antigenic peptides with MHC molecules.
    Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:409-16 PMID: 2639762
  15. A new human HLA class II-related locus, DM.
    Nature. 1991 Oct 10;353(6344):571-3 PMID: 1922365
  16. The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide.
    Cell. 1992 Feb 7;68(3):465-77 PMID: 1371238
  17. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules.
    Nature. 1994 Apr 7;368(6471):551-4 PMID: 8139689
  18. Mediation by HLA-DM of dissociation of peptides from HLA-DR.
    Nature. 1995 Jun 29;375(6534):802-6 PMID: 7596415
  19. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading.
    Cell. 1995 Jul 14;82(1):155-65 PMID: 7606781
  20. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide.
    Immunity. 1995 Aug;3(2):197-205 PMID: 7648393
  21. HLA-DM: an in vivo facilitator of MHC class II peptide loading.
    Immunity. 1995 Sep;3(3):259-62 PMID: 7552991
  22. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.
    Nature. 1995 Nov 30;378(6556):457-62 PMID: 7477400
  23. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM.
    Science. 1996 Oct 25;274(5287):618-20 PMID: 8849454
  24. Novel glycosylation of HLA-DRalpha disrupts antigen presentation without altering endosomal localization.
    J Immunol. 1998 May 1;160(9):4289-97 PMID: 9574531
  25. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation.
    Immunity. 1998 Sep;9(3):377-83 PMID: 9768757
  26. Crystal structure of mouse H2-M.
    Immunity. 1998 Sep;9(3):385-93 PMID: 9768758
  27. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II.
    Immunity. 1997 Oct;7(4):473-81 PMID: 9354468
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2002-07-15
Pages
173-83
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2193930
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]